17:37 , Sep 21, 2018 |  BC Week In Review  |  Financial News

DePinho's STAT3 company Tvardi raises $9M series A

Tvardi Therapeutics Inc. (Houston, Texas) raised $9 million on Sept. 20 in a series A round from Alexandria Venture Investments and other undisclosed institutional and private investors. Tvardi is developing inhibitors of signal transducer and...
13:46 , Sep 20, 2018 |  BC Extra  |  Financial News

DePinho's STAT3 company Tvardi raises $9M series A

Tvardi Therapeutics Inc. (Houston, Texas) raised $9 million in a series A round from Alexandria Venture Investments and other undisclosed institutional and private investors. Tvardi is developing inhibitors of signal transducer and activator of transcription...
07:00 , Oct 5, 2015 |  BC Week In Review  |  Financial News

Mirna Therapeutics completes IPO

Mirna Therapeutics Inc. (NASDAQ:MIRN), Austin, Texas   Business: Cancer   Date completed: 2015-10-01   Type: IPO   Raised: $43.8 million   Shares: 6.3 million   Price: $7   Shares after offering: 20.1 million   Underwriters:...
07:00 , Oct 5, 2015 |  BC Week In Review  |  Financial News

Mirna Therapeutics completes private placement

Mirna Therapeutics Inc. (NASDAQ:MIRN), Austin, Texas   Business: Cancer   Date completed: 2015-10-01   Type: Private placement   Raised: $16.8 million   Shares: 2.4 million   Price: $7   Shares after offering: 20.1 million  ...
07:00 , Sep 28, 2015 |  BC Week In Review  |  Financial News

Mirna amends IPO

Mirna Therapeutics Inc. , Austin, Texas   Business: Cancer   Date announced: 2015-09-18   Type: IPO   To be raised: Up to $69.8 million   Shares: 4.7 million   Price: $13-$15   Underwriters: Citigroup; Leerink...
07:00 , Sep 14, 2015 |  BC Week In Review  |  Financial News

Mirna amends IPO

Mirna Therapeutics Inc. , Austin, Texas   Business: Cancer   Date announced: 2015-09-11   Type: IPO   To be raised: Up to $80.5 million   Shares: TBD   Price: TBD   Underwriters: Citigroup; Leerink Partners;...
08:00 , Feb 5, 2015 |  BC Innovations  |  Finance

PPPs holding steady

BioCentury's annual analysis of public-private partnerships and early stage venture financing activity shows that the model of using PPPs to foster academic innovation is holding fast, and that academia is an active driver behind the...
07:00 , Apr 28, 2014 |  BioCentury  |  Emerging Company Profile

Aeglea: Old enzymes, new tricks

Aeglea BioTherapeutics Holdings LLC is developing enzymes to starve tumors that depend on outside sources of specific amino acids. Aeglea's engineered human enzymes may offer lower immunogenicity and greater activity than natural versions further along...
07:00 , Jul 30, 2012 |  BC Week In Review  |  Financial News

Cell Medica completes venture financing

Cell Medica Ltd. , London, U.K.   Business: Gene/Cell therapy, Infectious   Date completed: 7/23/12   Type: Venture financing   Raised: £17 million ($26.6 million)   Investors: Invesco; Imperial Innovations Group; Cancer Prevention and Research...
07:00 , Jun 11, 2012 |  BC Week In Review  |  Company News

Cancer Prevention and Research Institute of Texas (CPRIT), University of Texas MD Anderson Cancer Center cancer news

MD Anderson will resubmit for review a proposal for a $20 million incubator award made in March by CPRIT to the cancer center's Applied Cancer Science (IACS) and Rice University. The cancer center's president Ronald...